TY - JOUR
T1 - Integrative genomics identifies novel associations with apol1 risk genotypes in black neptune subjects
AU - Sampson, Matthew G.
AU - Robertson, Catherine C.
AU - Martini, Sebastian
AU - Mariani, Laura H.
AU - Lemley, Kevin V.
AU - Gillies, Christopher E.
AU - Otto, Edgar A.
AU - Kopp, Jeffrey B.
AU - Randolph, Anne
AU - Vega-Warner, Virginia
AU - Eichinger, Felix
AU - Nair, Viji
AU - Gipson, Debbie S.
AU - Cattran, Daniel C.
AU - Johnstone, Duncan B.
AU - O'Toole, John F.
AU - Bagnasco, Serena M.
AU - Song, Peter X.
AU - Barisoni, Laura
AU - Troost, Jonathan P.
AU - Kretzler, Matthias
AU - Sedor, John R.
N1 - Funding Information:
M.S. is a Carl Gottschalk Research Scholar of the American Society of Nephrology and is supported by the Charles Woodson Clinical Research Fund and by 1K08-DK100662-01 and M.K. is supported by U54-DK083912 Nephrotic Syndrome Study Network Consortium and P30-DK081943 George M. O''Brien Kidney Research Core Center at the University of Michigan. The Nephrotic Syndrome Study Network Consortium (NEPTUNE), U54-DK-083912, is a part of the National Center for Advancing Translational Sciences (NCATS) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, and the National Institute ofDiabetes, Digestive, and KidneyDiseases. RDCRNis an initiative of ORDR,NCATS.Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, NephCure Kidney International, and the Halpin Foundation. Parts of this study were presented at the 2014 American Society of Nephrology Annual Meeting, November 13-16, in Philadelphia, PA.
PY - 2016/3
Y1 - 2016/3
N2 - APOL1 variants have been associated with renal phenotypes in blacks. To refine clinical outcomes and discover mechanisms of APOL1-associated kidney injury,we analyzed clinical and genomic datasets derived from 90 black subjects in the Nephrotic Syndrome Study Network (NEPTUNE), stratified by APOL1 risk genotype. Ninety subjects with proteinuria 0.5 g/d were enrolled at first biopsy for primary nephrotic syndrome and followed. Clinical outcomes were determined, and renal histomorphometry and sequencing of Mendelian nephrotic syndrome genes were performed. APOL1 variants were genotyped, and glomerular and tubulointerstitial transcriptomes from protocol renal biopsy cores were analyzed for differential and correlative gene expression. Analyses were performed under the recessive model (high-risk genotype defined by two risk alleles). APOL1 high-risk genotype was significantly associated with a 17ml/min per 1.73m2 lower EGFR and a 69% reduction in the probability of complete remission at any time, independent of histologic diagnosis. Neither APOL1 risk group was enriched for Mendelian mutations. On renal biopsy, high-risk genotype was associated with increased fractional interstitial area, interstitial fibrosis, and tubular atrophy. Risk genotype was not associated with intrarenal APOL1 mRNA expression levels. Differential expression analysis demonstrated an increased steady-state level of five genes associated with the high-risk genotype (CXCL9, CXCL11, and UBD in glomerulus; SNOR14B and MUC13 in tubulointerstitium).APOL1tubulointerstitial coexpressionanalysis showedcoexpression ofAPOL1mRNAlevels with a group of intrarenal transcripts that together were associated with increased interstitial fibrosis and tubular atrophy. These data indicate the high-risk APOL1 genotype confers renal risk across histopathologic diagnoses.
AB - APOL1 variants have been associated with renal phenotypes in blacks. To refine clinical outcomes and discover mechanisms of APOL1-associated kidney injury,we analyzed clinical and genomic datasets derived from 90 black subjects in the Nephrotic Syndrome Study Network (NEPTUNE), stratified by APOL1 risk genotype. Ninety subjects with proteinuria 0.5 g/d were enrolled at first biopsy for primary nephrotic syndrome and followed. Clinical outcomes were determined, and renal histomorphometry and sequencing of Mendelian nephrotic syndrome genes were performed. APOL1 variants were genotyped, and glomerular and tubulointerstitial transcriptomes from protocol renal biopsy cores were analyzed for differential and correlative gene expression. Analyses were performed under the recessive model (high-risk genotype defined by two risk alleles). APOL1 high-risk genotype was significantly associated with a 17ml/min per 1.73m2 lower EGFR and a 69% reduction in the probability of complete remission at any time, independent of histologic diagnosis. Neither APOL1 risk group was enriched for Mendelian mutations. On renal biopsy, high-risk genotype was associated with increased fractional interstitial area, interstitial fibrosis, and tubular atrophy. Risk genotype was not associated with intrarenal APOL1 mRNA expression levels. Differential expression analysis demonstrated an increased steady-state level of five genes associated with the high-risk genotype (CXCL9, CXCL11, and UBD in glomerulus; SNOR14B and MUC13 in tubulointerstitium).APOL1tubulointerstitial coexpressionanalysis showedcoexpression ofAPOL1mRNAlevels with a group of intrarenal transcripts that together were associated with increased interstitial fibrosis and tubular atrophy. These data indicate the high-risk APOL1 genotype confers renal risk across histopathologic diagnoses.
UR - http://www.scopus.com/inward/record.url?scp=84959885241&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959885241&partnerID=8YFLogxK
U2 - 10.1681/ASN.2014111131
DO - 10.1681/ASN.2014111131
M3 - Article
C2 - 26150607
AN - SCOPUS:84959885241
SN - 1046-6673
VL - 27
SP - 814
EP - 823
JO - Journal of the American Society of Nephrology : JASN
JF - Journal of the American Society of Nephrology : JASN
IS - 3
ER -